Distinct requirements for activation of NKT and NK cells during viral infection

• Published in: The Journal of immunology (1950) Vol. 192; no. 8; pp. 3676 - 3685
• Main Authors: Tyznik, Aaron J, Verma, Shilpi, Wang, Qiao, Kronenberg, Mitchell, Benedict, Chris A
• Format: Journal Article
• Language: English
• Published: United States 15-04-2014
• Subjects: Animals; Cell Communication - immunology; Cytokines - biosynthesis; Cytokines - pharmacology; Dendritic Cells - immunology; Dendritic Cells - metabolism; Dendritic Cells - virology; Gene Expression; Immunity, Innate; Interferon-gamma - biosynthesis; Interleukin-12 - biosynthesis; Interleukin-12 - pharmacology; Killer Cells, Natural - drug effects; Killer Cells, Natural - immunology; Killer Cells, Natural - metabolism; Lymphocyte Activation - immunology; Mice; Mice, Knockout; Muromegalovirus - immunology; Natural Killer T-Cells - drug effects; Natural Killer T-Cells - immunology; Natural Killer T-Cells - metabolism; Receptors, Cytokine - genetics; Receptors, Cytokine - metabolism; Virus Diseases - genetics; Virus Diseases - immunology; Virus Diseases - metabolism
• DOI: 10.4049/jimmunol.1300837
• EISSN: 1550-6606
• ISSN: 0022-1767

NK cells are key regulators of innate defense against mouse CMV (MCMV). Like NK cells, NKT cells also produce high levels of IFN-γ rapidly after MCMV infection. However, whether similar mechanisms govern activation of these two cell types, as well as the significance of NKT cells for host resistance, remain unknown. In this article, we show that, although both NKT and NK cells are activated via cytokines, their particular cytokine requirements differ significantly in vitro and in vivo. IL-12 is required for NKT cell activation in vitro but is not sufficient, whereas NK cells have the capacity to be activated more promiscuously in response to individual cytokines from innate cells. In line with these results, GM-CSF-derived dendritic cells activated only NK cells upon MCMV infection, consistent with their virtual lack of IL-12 production, whereas Flt3 ligand-derived dendritic cells produced IL-12 and activated both NK and NKT cells. In vivo, NKT cell activation was abolished in IL-12(-/-) mice infected with MCMV, whereas NK cells were still activated. In turn, splenic NK cell activation was more IL-18 dependent. The differential requirements for IL-12 and IL-18 correlated with the levels of cytokine receptor expression by NK and NKT cells. Finally, mice lacking NKT cells showed reduced control of MCMV, and depleting NK cells further enhanced viral replication. Taken together, our results show that NKT and NK cells have differing requirements for cytokine-mediated activation, and both can contribute nonredundantly to MCMV defense, revealing that these two innate lymphocyte subsets function together to fine-tune antiviral responses.